David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared a post on LinkedIn:
“It was a great pleasure to share the podium with my colleague and friend Daniel Tan. Great discussion (Presidential symposium) on OS benefit of Osi+ChT in FLAURA2.”
More posts featuring WCLC2025 on OncoDaily.
Read More Highlights from WCLC25 on FLAURA2 trial.
